Convalescent Plasma to Stem Coronavirus: A Randomized, Blinded Phase 2 Study Comparing the Efficacy and Safety Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune Plasma) Among Adults Exposed to COVID-19

Name: Convalescent Plasma to Stem Coronavirus: A Randomized, Blinded Phase 2 Study Comparing the Efficacy and Safety Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune Plasma) Among Adults Exposed to COVID-19
Creator: Vivli
Published: 2025-08-12 15:49:06
License: 暂无描述

DataCite Commons2025-08-12 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00008965/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

Evaluate the efficacy of treatment with high-titer Anti- SARS-CoV-2 plasma versus control (SARS-CoV-2 non-immune plasma) in subjects exposed to Coronavirus disease (COVID-19) at day 28.

提供机构：

Vivli

创建时间：

2023-05-24